Download PDF
1 / Pages

Other users also viewed these articles

Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients Miguel A. Suárez-Santisteban; Gracia Santos-Díaz; Vanesa García-Bernalt; Ana M. Pérez-Pico; Esther Mingorance; Raquel Mayordomo; Pedro Dorado;
Nefrologia (English Version). 2024;44:382-95
Interleukin-17A: Potential mediator and therapeutic target in hypertension Raúl R. Rodrigues-Diez; Antonio Tejera-Muñoz; Macarena Orejudo; Laura Marquez-Exposito; Laura Santos-Sanchez; Sandra Rayego-Mateos; Elena Cantero-Navarro; Lucia Tejedor-Santamaria; Vanessa Marchant; Alberto Ortiz; Jesús Egido; Sergio Mezzano; Rafael Selgas; Juan F. Navarro-González; Jose M. Valdivielso; Carolina Lavoz; Marta Ruiz-Ortega;
Nefrologia (English Version). 2021;41:244-57
Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project Juan F. Navarro González; Alberto Ortiz; Ana Cebrián Cuenca; Marta Moreno Barón; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;
Nefrologia (English Version). 2024;44:807-17